Edwin M. Posadas

Medicine · Health Sciences

51h-index8.7kcitations419works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(177), Cancer Genomics and Diagnostics(52), Radiopharmaceutical Chemistry and Applications(46), Cancer Cells and Metastasis(40), Cancer, Hypoxia, and Metabolism(34)

Publications419 total

Additional file 1 of A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases
Figshare·2026Open Access
Additional file 1 of A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases
Figshare·2026Open Access
A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases
Figshare·2026Open Access
A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases
Figshare·2026Open Access
A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases
Journal of Experimental & Clinical Cancer Research·2025Open Access
ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignancies
Endocrine Related Cancer·2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
Journal of Clinical Oncology·2025· 3 cited
A Double-Blinded Placebo-Controlled Biomarker Stratified Randomized Trial of Apalutamide (APA) and Radiotherapy for Recurrent Prostate Cancer (NRG GU006, BALANCE trial)
International Journal of Radiation Oncology*Biology*Physics·2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imaging
Nature Reviews Urology·2025
P3.18.70 Combination of Osimertinib and Carotuximab for Advanced, EFGR-Mutated Non-Small Cell Lung Cancer Patients
Journal of Thoracic Oncology·2025
2393P Prospective monitoring of prostate specific membrane antigen (PSMA) in biochemically recurrent prostate cancer (BCR): Preliminary data from 1 Year follow-up
Annals of Oncology·2025
2433P Preliminary safety and clinical activity from a phase II study of apalutamide + carotuximab in advanced, castration-resistant prostate cancer
Annals of Oncology·2025
Tumor Extracellular Vesicle Digital Scoring Assays for Cancer Detection and Monitoring
Precision Chemistry·2025· 1 citedOpen Access
Click Chemistry-Mediated Enrichment of Tumor-Derived Extracellular Vesicles for RNA-Based Digital Scoring
2025
Noninvasive Assessment of β‐Secretase Activity Through Click Chemistry‐Mediated Enrichment of Neuronal Extracellular Vesicles to Detect Alzheimer's Disease (Adv. Sci. 26/2025)
Advanced Science·2025Open Access
Extracellular vesicle heterogeneity through the lens of multiomics
Cell Reports Medicine·2025· 18 citedOpen Access
Investigation of liver-specific gene expression signatures in prostate cancers prior to liver metastases.
Journal of Clinical Oncology·2025
Effect of emerin dysregulation on the very-small-nuclear phenotype and lineage plasticity associated with a clinically aggressive subtype of prostate cancer.
Journal of Clinical Oncology·2025
Prospective monitoring of prostate specific membrane antigen–positive biochemically recurrent prostate cancer (PSMA+ BCR): Preliminary data from 6-month PSMA follow-up.
Journal of Clinical Oncology·2025· 1 cited
Feasibility and acceptability of remote activity and patient-reported outcome monitoring in men with prostate cancer undergoing androgen deprivation therapy.
Journal of Clinical Oncology·2025
page 1 of 21Next →

Frequent Co-authors

Hsian‐Rong Tseng(12), Leland W.K. Chung(10), Yi‐Tsung Lu(8), Neil A. Bhowmick(6), Jake Lichterman(6), Shuang Hou(6), Jie‐Fu Chen(6), Dolores Di Vizio(5), Seth M. Steinberg(5), Elise C. Kohn(5), Sungyong You(5), Vatche G. Agopian(5), Yazhen Zhu(5), Haiyen E. Zhau(5), Felix Y. Feng(4), Chen Shao(4), Matthew B. Rettig(4), Valentina R. Minciacchi(3), Michael R. Freeman(3), Shelly C. Lu(3)